Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Glioma Epidemiology in the Central Tunisian Population: 1993-2012

  • Trabelsi, Saoussen (Department of Cytogenetics, Molecular genetics and Reproductive Biology, Farhet Hached University Hospital) ;
  • Brahim, Dorra H'mida-Ben (Department of Cytogenetics, Molecular genetics and Reproductive Biology, Farhet Hached University Hospital) ;
  • Ladib, Mohamed (Department of Neurosurgery, Sahloul University Hospital) ;
  • Mama, Nadia (Department of Radiology, Sahloul University Hospital) ;
  • Harrabi, Imed (Department of Community and Preventive Medicine, Farhet Hached University Hospital) ;
  • Tlili, Kalthoum (Department of Radiology, Sahloul University Hospital) ;
  • Yacoubi, Mohamed Tahar (Department of Cytopathology, Farhet Hached University Hospital) ;
  • Krifa, Hedi (Department of Neurosurgery, Sahloul University Hospital) ;
  • Hmissa, Sihem (Department of Cancer Registry of the Centre of Tunisia, Farhet Hached University Hospital) ;
  • Saad, Ali (Department of Cytogenetics, Molecular genetics and Reproductive Biology, Farhet Hached University Hospital) ;
  • Mokni, Moncef (Department of Cytopathology, Farhet Hached University Hospital)
  • Published : 2014.11.06
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Glioma is a heterogeneous central nervous system (CNS) tumor group that encompasses different histological subtypes with high variability in prognosis. The lesions account for almost 80% of primary malignant brain tumors. The aim of this study is to extend our understanding of the glioma epidemiology in the central Tunisian region. Materials and Methods: We analyzed 393 gliomas recorded in cancer registry of central Tunisia from 1993 to 2012. Crude incidence rates (CR) and world age-standardized rates (ASR) were estimated using annual population data size and age structure. Statistic correlations were established using Chi-square and Kaplan-Meier test. Results: Tunisian glioma patients were identified with a mean age at diagnosis of 48 years and 1.5 sex ratio (male/female). During the 19 years period of study the highest incidence value was observed in male group between 1998 and 2002 (CR: 0.28, ASR: 0.3). Incidence results underline increasing high grade glioma occurring in the adulthood in the last period (2007-2012). Median survival was 27 months, with 1-, 2- and 5-year survival rates of 42%, 30% and 26%, respectively. Survival was greater in patients with younger age, lower tumor grade, infratentrial tumor location and undergoing a palliative treatment. Conclusions: This central Tunisia gliomas registry study provides important information that could improve glioma management and healthcare practice.

Keywords

References

  1. Arshad H, Ahmad Z, Hasan SH (2010). Gliomas: correlation of histologic grade, Ki67 and p53 expression with patient survival. Asian Pac J Cancer Prev, 11, 1637-40.
  2. Barchana M, Margaliot M, Liphshitz I (2012). Changes in brain glioma incidence and laterality correlates with use of mobile phones--a nationwide population based study in Israel. Asian Pac J Cancer Prev, 13, 5857-63. https://doi.org/10.7314/APJCP.2012.13.11.5857
  3. Bhurgri Y, Bhurgri H, Kayani N, et al (2011). Trends and morphology of central nervous system malignancies in Karachi. Asian Pac J Cancer Prev, 12, 2013-7.
  4. Crocetti E, Trama A, Stiller C, et al (2012). Epidemiology of glial and non-glial brain tumours in Europe. Eur J Cancer, 48, 1532-42. https://doi.org/10.1016/j.ejca.2011.12.013
  5. Davis FG, Malmer BS, Aldape K, et al (2008). Issues of diagnostic review in brain tumor studies: from the Brain Tumor Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev, 17, 484-9. https://doi.org/10.1158/1055-9965.EPI-07-0725
  6. Dubrow R, Darefsky AS (2011). Demographic variation in incidence of adult glioma by subtype, United States, 1992-2007. BMC Cancer, 11, 325. https://doi.org/10.1186/1471-2407-11-325
  7. Hess KR, Broglio KR, Bondy ML (2004). Adult glioma incidence trends in the United States, 1977-2000. Cancer, 101, 2293-9. https://doi.org/10.1002/cncr.20621
  8. Jazayeri SB, Rahimi-Movaghar V, Shokraneh F, et al (2013). Epidemiology of primary CNS tumors in Iran: a systematic review. Asian Pac J Cancer Prev, 14, 3979-85. https://doi.org/10.7314/APJCP.2013.14.6.3979
  9. Larjavaara S, Mantyla R, Salminen T, et al (2007). Incidence of gliomas by anatomic location. Neuro Oncol, 9, 319-25. https://doi.org/10.1215/15228517-2007-016
  10. Louis DN, Holland EC, Cairncross JG (2001). Glioma classification: a molecular reappraisal. Am J Pathol, 159, 779-86. https://doi.org/10.1016/S0002-9440(10)61750-6
  11. Louis DN, Ohgaki H, Wiestler OD, et al (2007). The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol, 114, 97-109. https://doi.org/10.1007/s00401-007-0243-4
  12. Manoharan N, Julka PK, Rath GK (2012). Descriptive epidemiology of primary brain and CNS tumors in Delhi, 2003-2007. Asian Pac J Cancer Prev, 13, 637-40. https://doi.org/10.7314/APJCP.2012.13.2.637
  13. Mehrazin M, Rahmat H, Yavari P (2006). Epidemiology of primary intracranial tumors in Iran, 1978-2003. Asian Pac J Cancer Prev, 7, 283-8.
  14. Micheli A, Ciampichini R, Oberaigner W, et al (2009). The advantage of women in cancer survival: An analysis of EUROCARE-4 data. Eur J Cancer, 45, 1017-27. https://doi.org/10.1016/j.ejca.2008.11.008
  15. Missaoui N, Trabelsi A, Parkin DM, et al (2010). Trends in the incidence of cancer in the Sousse region, Tunisia, 1993-2006. Int J Cancer, 127, 2669-77. https://doi.org/10.1002/ijc.25490
  16. Ohgaki H, Kleihues P (2005). Epidemiology and etiology of gliomas. Acta Neuropathol, 109, 93-108. https://doi.org/10.1007/s00401-005-0991-y
  17. Schwartzbaum JA, Fisher JL, Aldape KD, et al (2006). Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol, 2, 494-503.

Cited by

  1. Insights into the clinical value of cyclin-dependent kinase 5 in glioma: a retrospective study vol.13, pp.1, 2015, https://doi.org/10.1186/s12957-015-0629-z
  2. S100A4 Expression is Closely Linked to Genesis and Progression of Glioma by Regulating Proliferation, Apoptosis, Migration and Invasion vol.16, pp.7, 2015, https://doi.org/10.7314/APJCP.2015.16.7.2883
  3. Long non-coding RNA RP5-833A20.1 inhibits proliferation, metastasis and cell cycle progression by suppressing the expression of NFIA in U251 cells vol.14, pp.6, 2016, https://doi.org/10.3892/mmr.2016.5854
  4. Celastrus orbiculatus extract inhibits the migration and invasion of human glioblastoma cells in vitro vol.16, pp.1, 2016, https://doi.org/10.1186/s12906-016-1232-8
  5. Central, Extraventricular and Atypical Neurocytomas: a Clinicopathologic Study of 35 Cases from Pakistan Plus a Detailed Review of the Published Literature vol.17, pp.3, 2016, https://doi.org/10.7314/APJCP.2016.17.3.1565
  6. Induction of S-Phase Arrest in Human Glioma Cells by Selenocysteine, a Natural Selenium-Containing Agent Via Triggering Reactive Oxygen Species-Mediated DNA Damage and Modulating MAPKs and AKT Pathways vol.41, pp.6, 2016, https://doi.org/10.1007/s11064-016-1854-8
  7. Molecular Diagnostic and Prognostic Subtyping of Gliomas in Tunisian Population vol.54, pp.4, 2017, https://doi.org/10.1007/s12035-016-9805-6